News Focus
News Focus
icon url

ProLiberty

04/08/25 2:57 PM

#434696 RE: Birdbrain Ideas #434694

The market clearly thinks the company will burn its cash and go bankrupt. If an offer is made now for something above cash level of $0.75 the BOD would have to consider it. One would hope that it would finally get other BP to get off their asses and make a bid for a drug protected out to 2039. Time for any bid that hopefully draws one or more additional competitive bids.

With the stock languishing at a big discount to cash it makes it all the more likely that one or more newer investors at these levels demand value realization at $0.75. It is actually surprising we haven't seen a bid for $1-$1.50... I don't think shareholders will reject a 200%+ premium.
icon url

JRoon71

04/08/25 3:52 PM

#434700 RE: Birdbrain Ideas #434694

It would certainly be nice to know which investors they represent. With the number of shares they claim to own (15M??), there should be a 13f somewhere for someone. I am wondering if we will see a 13f next quarter (this quarter's filing). 15M shares wouldn't require an immediate 13d filing.

But Michael Torok and his partner Bradley Radoff are not registered with the SEC, so they are not actual investment advisors. JEC Capital (or any variation) is also not registered as an investment advisor. I know in following some prior SEC filings, they oversee a family foundation, a couple of trusts, themselves personally, and some other entities.